Hyper-personalization AI

Showing 11431 articles
Business

Ionis Pharmaceuticals Gains Momentum with Key Approvals and Pipeline Successes

Recent regulatory wins for Dawnzera in Europe and breakthrough therapy designations from the FDA, alongside positive Phase 3 data from a partner, bolster Ionis's late-stage portfolio. However, insider stock sales and a trimmed stake by a major investor highlight the ongoing challenge of converting scientific promise into sustained commercial success.

Business

From Digital Showrooms to AI: The Auto Industry's Unending Quest for a Silver Bullet

The automotive sector has a long history of embracing transformative technologies—from digital retail to vehicle subscriptions—that promised salvation but delivered incremental change at best. As artificial intelligence emerges as the latest panacea, seasoned dealers and analysts urge caution, pointing to a persistent pattern of overpromising and a failure to address core consumer concerns.